Apollomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	32.06	32.68	46.74
Short-Term Investments	5.76	21.94	47.74
Cash & Cash Equivalents	37.82	54.61	94.48
Cash Growth	-30.76%	-42.20%	-
Other Current Assets	2.11	1.18	4.88
Total Current Assets	39.93	55.79	99.37
Property, Plant & Equipment	0.59	1.48	1.32
Long-Term Investments	0	4.31	7.84
Goodwill and Intangibles	14.76	14.78	14.8
Other Long-Term Assets	0.12	0.12	0.11
Total Long-Term Assets	15.46	20.69	24.07
Total Assets	55.39	76.48	123.44
Accounts Payable	9.16	11.68	11.4
Current Debt	4.39	0.61	0.51
Other Current Liabilities	0	0.07	1.65
Total Current Liabilities	13.56	12.36	13.56
Long-Term Debt	0.27	0.38	0.53
Other Long-Term Liabilities	0.33	511.86	322.22
Total Long-Term Liabilities	0.6	512.24	322.74
Total Liabilities	14.15	524.6	0
Total Debt	4.66	0.99	1.04
Debt Growth	370.33%	-4.34%	-
Retained Earnings	-646.97	-474.6	-235.44
Shareholders' Equity	41.23	-448.12	-212.86
Net Cash / Debt	33.16	53.62	93.45
Net Cash / Debt Growth	-38.17%	-42.62%	-
Working Capital	26.37	43.43	85.81
Book Value Per Share	0.46	-33.37	-33.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).